The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Long-term l -Arginine Supplementation Improves Small-Vessel Coronary Endothelial Function in Humans
Abstract
Background —Coronary endothelial dysfunction is characterized by an imbalance between endothelium-derived vasodilating and vasoconstricting factors and coronary vasoconstriction in response to the endothelium-dependent vasodilator acetylcholine. Thus, the present double-blind, randomized study was designed to test the hypothesis that long-term, 6-month supplementation of l -arginine, the precursor of the endothelium-derived vasodilator NO, reverses coronary endothelial dysfunction to acetylcholine in humans with nonobstructive coronary artery disease. Methods and Results —Twenty-six patients without significant coronary artery disease on coronary angiography and intravascular ultrasound were blindly randomized to either oral l -arginine or placebo, 3 g TID. Endothelium-dependent coronary blood flow reserve to acetylcholine (10 −6 to 10 −4 mol/L) was assessed at baseline and after 6 months of therapy. There was no difference between the two study groups in clinical characteristics or in the coronary blood flow in the response to acetylcholine at baseline. After 6 months, the coronary blood flow in response to acetylcholine in the subjects who were taking l -arginine increased compared with the placebo group (149±20% versus 6±9%, P <0.05). This was associated with a decrease in plasma endothelin concentrations and an improvement in patients’ symptoms scores in the l -arginine treatment group compared with the placebo group. Conclusions —Long-term oral l -arginine supplementation for 6 months in humans improves coronary small-vessel endothelial function in association with a significant improvement in symptoms and a decrease in plasma endothelin concentrations. This study proposes a role for l -arginine as a therapeutic option for patients with coronary endothelial dysfunction and nonobstructive coronary artery disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Mancini, G. B. J., Henry, G. C., Macaya, C., O'Neill, B. J., Pucillo, A. L., Carere, R. G., Wargovich, T. J., Mudra, H., Lu¨scher, T. F., Klibaner, M. I., et al. (1996) · Circulation · doi:10.1161/01.cir.94.3.258 · Cited by 1,057
Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.
Boulanger, C., & Lüscher, T. F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114477 · Cited by 1,045
Zeiher, A. M., Drexler, H., Wollschläger, H., & Just, H. (1991) · Circulation · doi:10.1161/01.cir.83.2.391 · Cited by 995
L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.
Creager, M. A., Gallagher, S. J., Girerd, X. J., Coleman, S. M., Dzau, V. J., & Cooke, J. P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115987 · Cited by 813
Drexler, H., Zeiher, A. M., Meinzer, K., & Just, H. (1991) · The Lancet · doi:10.1016/0140-6736(91)92372-9 · Cited by 802
Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.
Cooke, J. P., Singer, A. H., Tsao, P., Zera, P., Rowan, R. A., & Billingham, M. E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115937 · Cited by 687
Clancy, R. M., Leszczynska-Piziak, J., & Abramson, S. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115929 · Cited by 686 · cited 1×
“NO can inhibit monocyte adhesion to the endothelium(1,31) and may also inhibit the production of superoxide anion by activated neutrophils.(34) Thus, it may be speculated that long-term L-arginine administration improves coronary endothelial function by attenuating the progression of coronary atherosclerosis.”
BackgroundYang, Z. H., Richard, V, von Segesser, L., Bauer, E., Stulz, P., Turina, M., & Lüscher, T. F. (1990) · Circulation · doi:10.1161/01.cir.82.1.188 · Cited by 439
Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.
Clarkson, P., Adams, M. R., Powe, A. J., Donald, A. E., McCredie, R., Robinson, J., McCarthy, S. N., Keech, A., Celermajer, D. S., & Deanfield, J. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118632 · Cited by 412
Cited by
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595
Self-citationChiu, J.-J., & Chien, S. (2011) · Physiological Reviews · doi:10.1152/physrev.00047.2009 · Cited by 2,280
Endothelial Dysfunction: A Marker of Atherosclerotic Risk
Bonetti, P. O., Lerman, L. O., & Lerman, A. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000051384.43104.fc · Cited by 2,200
Self-citationLong-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction
Suwaidi, J. A., Hamasaki, S., Higano, S. T., Nishimura, R. A., Holmes, D. R., & Lerman, A. (2000) · Circulation · doi:10.1161/01.cir.101.9.948 · Cited by 2,043
Self-citationThe clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749
Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000134 · Cited by 1,059
Self-citationTamis-Holland, J. E., Jneid, H., Reynolds, H. R., Agewall, S., Brilakis, E. S., Brown, T. M., Lerman, A., Cushman, M., Kumbhani, D. J., Arslanian-Engoren, C., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000670 · Cited by 994
Self-citationVascular nitric oxide: Beyond eNOS
Zhao, Y., Vanhoutte, P. M., & Leung, S. W. S. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.09.002 · Cited by 826
Bairey Merz, C. N., Pepine, C. J., Walsh, M. N., Fleg, J. L., Camici, P. G., Chilian, W. M., Clayton, J. A., Cooper, L. S., Crea, F., Di Carli, M., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024534 · Cited by 748
Women and Ischemic Heart Disease
Shaw, L. J., Bugiardini, R., & Merz, C. N. B. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.098 · Cited by 662
Ito, A., Tsao, P. S., Adimoolam, S., Kimoto, M., Ogawa, T., & Cooke, J. P. (1999) · Circulation · doi:10.1161/01.cir.99.24.3092 · Cited by 631
Does ADMA Cause Endothelial Dysfunction?
Cooke, J. P. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2032 · Cited by 581
Reis, S. E., Holubkov, R., Smith, A. J. C., Kelsey, S. F., Sharaf, B. L., Reichek, N., Rogers, W. J., Merz, C. N. B., Sopko, G., & Pepine, C. J. (2001) · American Heart Journal · doi:10.1067/mhj.2001.114198 · Cited by 551
Angina With “Normal” Coronary Arteries: A Changing Philosophy
Bugiardini, R., & Bairey Merz, C. N. (2005) · JAMA · doi:10.1001/jama.293.4.477 · Cited by 519
Nitric oxide and atherosclerosis: An update
Napoli, C., de Nigris, F., Williams-Ignarro, S., Pignalosa, O., Sica, V., & Ignarro, L. J. (2006) · Nitric Oxide · doi:10.1016/j.niox.2006.03.011 · Cited by 463
Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process
Moens, A. L., Claeys, M. J., Timmermans, J. P., & Vrints, C. J. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.04.013 · Cited by 448
Gluckman, T. J., Bhave, N. M., Allen, L. A., Chung, E. H., Spatz, E. S., Ammirati, E., Baggish, A. L., Bozkurt, B., Cornwell, W. K., Harmon, K. G., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.02.003 · Cited by 389
Diabetes-induced Coronary Vascular Dysfunction Involves Increased Arginase Activity
Romero, M. J., Platt, D. H., Tawfik, H. E., Labazi, M., El-Remessy, A. B., Bartoli, M., Caldwell, R. B., & Caldwell, R. W. (2008) · Circulation Research · doi:10.1161/circresaha.107.155028 · Cited by 386
Protective role of endothelial nitric oxide synthase
Albrecht, E. W., Stegeman, C. A., Heeringa, P., Henning, R. H., & van Goor, H. (2003) · The Journal of Pathology · doi:10.1002/path.1250 · Cited by 376
Nitric Oxide and Atherosclerosis
Napoli, C., & Ignarro, L. J. (2001) · Nitric Oxide · doi:10.1006/niox.2001.0337 · Cited by 368
Oxidative Stress as a Mediator of Cardiovascular Disease
Elahi, M. M., Kong, Y. X., & Matata, B. M. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.5.9441 · Cited by 360
Schulman, S. P., Becker, L. C., Kass, D. A., Champion, H. C., Terrin, M. L., Forman, S., Ernst, K. V., Kelemen, M. D., Townsend, S. N., Capriotti, A., et al. (2006) · JAMA · doi:10.1001/jama.295.1.58 · Cited by 357
Dietary modulation of endothelial function: implications for cardiovascular disease
Brown, A. A., & Hu, F. B. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.4.673 · Cited by 356
The l-arginine paradox: Importance of the l-arginine/asymmetrical dimethylarginine ratio
BODEBOGER, S., SCALERA, F., & IGNARRO, L. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.002 · Cited by 347
Kaski, J.-C., Crea, F., Gersh, B. J., & Camici, P. G. (2018) · Circulation · doi:10.1161/circulationaha.118.031373 · Cited by 340
The Clinical Pharmacology of L-Arginine
Böger, R. H., & Bode-Böger, S. M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.79 · Cited by 331
Arginine Therapy: A New Treatment for Pulmonary Hypertension in Sickle Cell Disease?
Morris, C. R., Morris, S. M., Hagar, W., van Warmerdam, J., Claster, S., Kepka-Lenhart, D., Machado, L., Kuypers, F. A., & Vichinsky, E. P. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-967oc · Cited by 329
Emergence of Nonobstructive Coronary Artery Disease
Pepine, C. J., Ferdinand, K. C., Shaw, L. J., Light-McGroary, K. A., Shah, R. U., Gulati, M., Duvernoy, C., Walsh, M. N., & Bairey Merz, C. N. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.876 · Cited by 311
Coronary Microvascular Dysfunction, Microvascular Angina, and Treatment Strategies
Marinescu, M. A., Löffler, A. I., Ouellette, M., Smith, L., Kramer, C. M., & Bourque, J. M. (2015) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2014.12.008 · Cited by 302
Padro, T., Manfrini, O., Bugiardini, R., Canty, J., Cenko, E., De Luca, G., Duncker, D. J., Eringa, E. C., Koller, A., Tousoulis, D., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa003 · Cited by 294
Arginine Nutrition and Cardiovascular Function
Wu, G., & Meininger, C. J. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.11.2626 · Cited by 286
Role of endothelial dysfunction in insulin resistance
Hsueh, W. A., & Quiñones, M. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00611-8 · Cited by 276
Imamura, M., Biro, S., Kihara, T., Yoshifuku, S., Takasaki, K., Otsuji, Y., Minagoe, S., Toyama, Y., & Tei, C. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01467-x · Cited by 276
Sex differences in cardiovascular disease – Impact on care and outcomes
Humphries, K. H., Izadnegahdar, M., Sedlak, T., Saw, J., Johnston, N., Schenck-Gustafsson, K., Shah, R. U., Regitz-Zagrosek, V., Grewal, J., Vaccarino, V., et al. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.04.001 · Cited by 273
Raitakari, O. T., & Celermajer, D. S. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00277.x · Cited by 272
Risk assessment for the amino acids taurine, l-glutamine and l-arginine
Shao, A., & Hathcock, J. N. (2008) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2008.01.004 · Cited by 265
Arginine and Endothelial Function
Gambardella, J., Khondkar, W., Morelli, M. B., Wang, X., Santulli, G., & Trimarco, V. (2020) · Biomedicines · doi:10.3390/biomedicines8080277 · Cited by 253
Nitric oxide and the endothelium: History and impact on cardiovascular disease
Yetik-Anacak, G., & Catravas, J. D. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.08.002 · Cited by 253
Lucotti, P., Setola, E., Monti, L. D., Galluccio, E., Costa, S., Sandoli, E. P., Fermo, I., Rabaiotti, G., Gatti, R., & Piatti, P. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00002.2006 · Cited by 249
Morita, M., Hayashi, T., Ochiai, M., Maeda, M., Yamaguchi, T., Ina, K., & Kuzuya, M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.029 · Cited by 140
L-Arginine as a Potential Ergogenic Aid in Healthy Subjects
Álvares, T. S., Meirelles, C. M., Bhambhani, Y. N., Paschoalin, V. M. F., & Gomes, P. S. C. (2011) · Sports Medicine · doi:10.2165/11538590-000000000-00000 · Cited by 138
Cooke, J. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430082100 · Cited by 135
N., C., & J., C. (2002) · Diabetologia · doi:10.1007/s00125-002-0975-6 · Cited by 116
Liu, T.-H., Wu, C.-L., Chiang, C.-W., Lo, Y.-W., Tseng, H.-F., & Chang, C.-K. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.05.005 · Cited by 101
Biochemical responses of healthy subjects during dietary supplementation with L-arginine
Evans, R. W., Fernstrom, J. D., Thompson, J., Morris, S. M., & Kuller, L. H. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2004.03.005 · Cited by 97
Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects
Alvares, T., Conte-Junior, C., Silva, J., & Paschoalin, V. M. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-54 · Cited by 76
l-Arginine transporters in cardiovascular disease: A novel therapeutic target
Chin-Dusting, J. P. F., Willems, L., & Kaye, D. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.08.001 · Cited by 69
In Vivo and In Vitro Evidence for Impaired Arginine Transport in Human Heart Failure
Kaye, D. M., Ahlers, B. A., Autelitano, D. J., & Chin-Dusting, J. P. F. (2000) · Circulation · doi:10.1161/01.cir.102.22.2707 · Cited by 68
Menafra, D., de Angelis, C., Garifalos, F., Mazzella, M., Galdiero, G., Piscopo, M., Castoro, M., Verde, N., Pivonello, C., Simeoli, C., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01704-3 · Cited by 15
Metadata
- Authors
- Lerman, A., Burnett, J. C., Higano, S. T., McKinley, L. J., & Holmes, D. R.
- Venue
- Circulation
- Published
- 1998-06-02
- Volume
- 97
- Issue
- 21
- Pages
- 2123-2128
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2044013576
- Cited by
- 426
- References
- 34
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.